|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
FORM 8-K
CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 13, 2017
OMNI HEALTH, INC. (Exact name of registrant as specified in charter)
| |||
|
Nevada |
333-195397 |
46-4597341 | |
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) | |
|
| |||
|
5966 W 16th Avenue, Hialeah, FL |
33012 | ||
|
(Address of principal executive offices) |
(Zip Code) | ||
|
305-558-8551 Registrant’s telephone number
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c)) | |||
1
|
As used in this report, the terms "we", "us", "our", the "Company" refer to Omni Health, Inc., a Nevada corporation.
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.
On July 13, 2017, Michael Hawkins resigned as the Chief Financial Officer of the Company, effective as of that date. The resignation of Mr. Hawkins did not result from any disagreement with the Company.
On July 13, 2017, Andrey Soloviev was appointed as the interim Chief Financial Officer of the Company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
OMNI HEALTH, INC Date: July 21, 2017 By: /s/ Andrey Soloviev Andrey Soloviev, Chief Executive Officer
|
2